1. Home
  2. STEL vs TNGX Comparison

STEL vs TNGX Comparison

Compare STEL & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellar Bancorp Inc.

STEL

Stellar Bancorp Inc.

HOLD

Current Price

$32.33

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$9.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEL
TNGX
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STEL
TNGX
Price
$32.33
$9.12
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$31.33
$12.50
AVG Volume (30 Days)
241.2K
2.7M
Earning Date
01-29-2026
11-04-2025
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
1.94
N/A
Revenue
$416,539,000.00
$66,501,000.00
Revenue This Year
N/A
$53.01
Revenue Next Year
$3.41
N/A
P/E Ratio
$16.72
N/A
Revenue Growth
N/A
53.29
52 Week Low
$24.13
$1.03
52 Week High
$32.74
$11.20

Technical Indicators

Market Signals
Indicator
STEL
TNGX
Relative Strength Index (RSI) 63.89 49.09
Support Level $31.46 $8.89
Resistance Level $32.74 $10.22
Average True Range (ATR) 0.62 0.62
MACD 0.06 -0.15
Stochastic Oscillator 69.85 10.83

Price Performance

Historical Comparison
STEL
TNGX

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: